Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Bone Care International LLC et al v. Pentech Pharmaceuticals, Inc.
Case Number:
1:08-cv-01083
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 22, 2012
Genzyme Tops Cobrek In Kidney Drug Patent Fight
An Illinois federal judge ruled Thursday that a Genzyme Corp. patent covering kidney disease treatment Hectorol is valid and enforceable in the drugmaker's suit against Cobrek Pharmaceuticals Inc. over a generic version of a renal drug that Cobrek had conceded infringing.
-
September 20, 2010
Genzyme Defeats 1 Of 3 Defenses In Hectorol IP Suit
A federal judge has dismissed one inequitable conduct defense asserted by Cobrek Pharmaceuticals Inc. in a patent infringement suit brought by Genzyme Corp. over kidney disease treatment Hectorol, but left two other inequitable conduct defenses intact.